Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Virella

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Diabetes Care|March 22, 2013
Baseline markers of inflammation are associated with progression to macroalbuminuria in type 1 diabetic subjectsMaria F Lopes-Virella, Nathaniel L Baker, Kelly J Hunt, et al.
Diabetes Care|April 9, 2015
Longitudinal Association Between Endothelial Dysfunction, Inflammation, and Clotting Biomarkers With Subclinical Atherosclerosis in Type 1 Diabetes: An Evaluation of the DCCT/EDIC CohortKelly J Hunt, Nathaniel L Baker, Patricia A Cleary, et al.
Journal of Diabetes and Its Complications|July 5, 2005
Markers of endothelial dysfunction in the prediction of coronary artery disease in type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications StudyTina Costacou, Maria F Lopes-Virella, Janice C Zgibor, et al.
Diabetes Care|April 19, 2012
High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetesMaria F Lopes-Virella, Nathaniel L Baker, Kelly J Hunt, et al.
Journal of Lipid Research|February 4, 2003
Autoimmune response to advanced glycosylation end-products of human LDLGabriel Virella, Suzanne R Thorpe, Nathan L Alderson, et al.
Clinical Immunology (Orlando, Fla.)|March 29, 2011
Oxidized LDL immune complexes stimulate collagen IV production in mesangial cells via Fc gamma receptors I and IIISouzan A Abdelsamie, Yanchun Li, Yan Huang, et al.
Journal of Lipid Research|July 20, 2004
Definition of the immunogenic forms of modified human LDL recognized by human autoantibodies and by rabbit hyperimmune antibodiesGabriel Virella, Suzanne R Thorpe, Nathan L Alderson, et al.
Journal of Clinical Lipidology|May 3, 2019
Glycosylated sphingolipids and progression to kidney dysfunction in type 1 diabetesMaria F Lopes-Virella, Nathaniel L Baker, Kelly J Hunt, et al.
Atherosclerosis|November 26, 2013
Oxidized LDL and AGE-LDL in circulating immune complexes strongly predict progression of carotid artery IMT in type 1 diabetesKelly J Hunt, Nathaniel Baker, Patricia Cleary, et al.
Diabetes|June 21, 2019
Immune Complexes and the Risk of CVD in Type 1 DiabetesMaria F Lopes-Virella, Ionut Bebu, Kelly J Hunt, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Diabetes Care|March 22, 2013
Baseline markers of inflammation are associated with progression to macroalbuminuria in type 1 diabetic subjectsMaria F Lopes-Virella, Nathaniel L Baker, Kelly J Hunt, et al.
Diabetes Care|April 9, 2015
Longitudinal Association Between Endothelial Dysfunction, Inflammation, and Clotting Biomarkers With Subclinical Atherosclerosis in Type 1 Diabetes: An Evaluation of the DCCT/EDIC CohortKelly J Hunt, Nathaniel L Baker, Patricia A Cleary, et al.
Journal of Diabetes and Its Complications|July 5, 2005
Markers of endothelial dysfunction in the prediction of coronary artery disease in type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications StudyTina Costacou, Maria F Lopes-Virella, Janice C Zgibor, et al.
Diabetes Care|April 19, 2012
High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetesMaria F Lopes-Virella, Nathaniel L Baker, Kelly J Hunt, et al.
Journal of Lipid Research|February 4, 2003
Autoimmune response to advanced glycosylation end-products of human LDLGabriel Virella, Suzanne R Thorpe, Nathan L Alderson, et al.
Clinical Immunology (Orlando, Fla.)|March 29, 2011
Oxidized LDL immune complexes stimulate collagen IV production in mesangial cells via Fc gamma receptors I and IIISouzan A Abdelsamie, Yanchun Li, Yan Huang, et al.
Journal of Lipid Research|July 20, 2004
Definition of the immunogenic forms of modified human LDL recognized by human autoantibodies and by rabbit hyperimmune antibodiesGabriel Virella, Suzanne R Thorpe, Nathan L Alderson, et al.
Journal of Clinical Lipidology|May 3, 2019
Glycosylated sphingolipids and progression to kidney dysfunction in type 1 diabetesMaria F Lopes-Virella, Nathaniel L Baker, Kelly J Hunt, et al.
Atherosclerosis|November 26, 2013
Oxidized LDL and AGE-LDL in circulating immune complexes strongly predict progression of carotid artery IMT in type 1 diabetesKelly J Hunt, Nathaniel Baker, Patricia Cleary, et al.
Diabetes|June 21, 2019
Immune Complexes and the Risk of CVD in Type 1 DiabetesMaria F Lopes-Virella, Ionut Bebu, Kelly J Hunt, et al.
Pageof 5